CD86 and metabolic dysfunction-associated steatotic liver disease: The analysis revealed a higher fraction of immune cell infiltration in the NAFLD group, including infiltration of immune cells such as M1 macrophages and neutrophils and expression of the immune checkpoint markers such as CD86 and PDCD1 (Fig. 7a, b).